PATENT CLAIM ANALYSIS

Application Number: 15981732
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["514", "318000"]

Abstract:
This disclosure relates to use of certain aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease such as scleroderma, lupus, arthritis and related conditions in a mammal.

Claim (Index 14):
The compound of  claim 9 , which is or a stereoisomer thereof, or a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.16129
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15084252', '15852977', '15828163', '14890147', '15499535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7937634479306006
- 35 USC 102 Novelty (BERT): 0.5641714675322208
- Combined Prediction Score: 0.7708042498907627
- Mean Citation Score: 312.99968
- Max Citation Score: 492.09747
- Similarity Product: 320.1998910450983

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test